CTI BioPharma Shares Outstanding 2006-2018 | CTIC

CTI BioPharma shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • CTI BioPharma shares outstanding for the quarter ending June 30, 2018 were 0.058B, a 81.63% increase year-over-year.
  • CTI BioPharma 2017 shares outstanding were 0.036B, a 30.4% increase from 2016.
  • CTI BioPharma 2016 shares outstanding were 0.028B, a 48.37% increase from 2015.
  • CTI BioPharma 2015 shares outstanding were 0.019B, a 26.82% increase from 2014.
CTI BioPharma Annual Shares Outstanding
(Millions of Shares)
2017 36
2016 28
2015 19
2014 15
2013 11
2012 6
2011 3
2010 2
2009 2
2008 0
2007 0
2006 0
2005 0
CTI BioPharma Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 58
Q1 2018 50
Q4 2017 36
Q3 2017 43
Q2 2017 32
Q1 2017 28
Q4 2016 28
Q3 2016 28
Q2 2016 28
Q1 2016 28
Q4 2015 19
Q3 2015 18
Q2 2015 18
Q1 2015 17
Q4 2014 15
Q3 2014 15
Q2 2014 14
Q1 2014 14
Q4 2013 11
Q3 2013 11
Q2 2013 11
Q1 2013 11
Q4 2012 6
Q3 2012 5
Q2 2012 4
Q1 2012 4
Q4 2011 3
Q3 2011 4
Q2 2011 3
Q1 2011 3
Q4 2010 2
Q3 2010 2
Q2 2010 2
Q1 2010 2
Q4 2009 2
Q3 2009 2
Q2 2009 1
Q1 2009 1
Q4 2008 0
Q3 2008 0
Q2 2008 0
Q1 2008 0
Q4 2007 0
Q3 2007 0
Q2 2007 0
Q1 2007 0
Q4 2006 0
Q3 2006 0
Q2 2006 0
Q1 2006 0
Q4 2005 0
Q3 2005 0
Q2 2005 0
Q1 2005 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.113B $0.025B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.909B 11.42
Zoetis (ZTS) United States $44.708B 32.44
Tilray (TLRY) United States $13.808B 0.00
Grifols (GRFS) Spain $13.472B 16.44
Neurocrine Biosciences (NBIX) United States $10.376B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.597B 14.12
Nektar Therapeutics (NKTR) United States $8.725B 10.20
Ionis Pharmaceuticals (IONS) United States $6.499B 0.00
Catalent (CTLT) United States $6.299B 27.11
Sage Therapeutics (SAGE) United States $5.667B 0.00
United Therapeutics (UTHR) United States $5.533B 7.10
Impax Laboratories (AMRX) United States $5.513B 29.32
Loxo Oncology (LOXO) United States $5.126B 0.00
FibroGen (FGEN) United States $4.699B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.839B 14.87
Endo (ENDP) Ireland $3.818B 5.48
Madrigal Pharmaceuticals (MDGL) United States $3.175B 0.00
Aerie Pharmaceuticals (AERI) United States $2.715B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.671B 0.00
USANA Health Sciences (USNA) United States $2.589B 22.81
TESARO (TSRO) United States $2.432B 0.00
Heron Therapeutics (HRTX) United States $2.357B 0.00
Xencor (XNCR) United States $2.030B 0.00
PTC Therapeutics (PTCT) United States $1.997B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.968B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.653B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.567B 19.16
Portola Pharmaceuticals (PTLA) United States $1.564B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.514B 0.00
Corcept Therapeutics (CORT) United States $1.492B 22.96
Zogenix (ZGNX) United States $1.491B 0.00
TherapeuticsMD (TXMD) United States $1.345B 0.00
Esperion Therapeutics (ESPR) United States $1.339B 0.00
Tricida (TCDA) United States $1.294B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.187B 0.00
ImmunoGen (IMGN) United States $1.180B 0.00
Endocyte (ECYT) United States $1.094B 0.00
Radius Health (RDUS) United States $0.903B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.784B 0.00
Karyopharm Therapeutics (KPTI) United States $0.775B 0.00
Flexion Therapeutics (FLXN) United States $0.701B 0.00
GlycoMimetics (GLYC) United States $0.601B 0.00
Collegium Pharmaceutical (COLL) United States $0.588B 0.00
Dova Pharmaceuticals (DOVA) United States $0.587B 0.00
ChemoCentryx (CCXI) United States $0.584B 34.15
Crinetics Pharmaceuticals (CRNX) United States $0.564B 0.00
Dermira (DERM) United States $0.529B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.526B 0.00
Akebia Therapeutics (AKBA) United States $0.508B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.500B 0.00
ArQule (ARQL) United States $0.495B 0.00
OptiNose (OPTN) United States $0.486B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.466B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.446B 30.40
Forty Seven (FTSV) United States $0.444B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.430B 0.00
Odonate Therapeutics (ODT) United States $0.428B 0.00
Minerva Neurosciences (NERV) United States $0.421B 0.00
Siga Technologies (SIGA) United States $0.416B 0.00
Xeris Pharmaceuticals (XERS) United States $0.404B 0.00
Aquestive Therapeutics (AQST) United States $0.397B 0.00
Zafgen (ZFGN) United States $0.386B 0.00
Aclaris Therapeutics (ACRS) United States $0.377B 0.00
Mast Therapeutics (SVRA) United States $0.376B 0.00
Depomed (ASRT) United States $0.368B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.362B 0.00
Concert Pharmaceuticals (CNCE) United States $0.358B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.357B 0.00
ElectroCore (ECOR) United States $0.351B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.347B 0.00
KalVista Pharmaceuticals (KALV) United States $0.338B 0.00
Majesco Entertainment (PTE) United States $0.314B 0.00
Translate Bio (TBIO) United States $0.311B 0.00
CASI Pharmaceuticals (CASI) United States $0.295B 0.00
MEI Pharma (MEIP) United States $0.288B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.278B 0.00
Aldeyra Therapeutics (ALDX) United States $0.271B 0.00
Tyme Technologies (TYME) United States $0.264B 0.00
Aratana Therapeutics (PETX) United States $0.261B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.253B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.249B 0.00
Ocular Therapeutix (OCUL) United States $0.246B 0.00
Ardelyx (ARDX) United States $0.244B 0.00
IMV INC (IMV) Canada $0.243B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.240B 0.00
Opexa Therapeutics (ACER) United States $0.233B 0.00
Neon Therapeutics (NTGN) United States $0.226B 0.00
Melinta Therapeutics (MLNT) United States $0.224B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Calithera Biosciences (CALA) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Jounce Therapeutics (JNCE) United States $0.200B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.195B 0.00
Molecular Templates (MTEM) United States $0.189B 0.00
Achaogen (AKAO) United States $0.186B 0.00
Redhill Biopharma (RDHL) Israel $0.175B 0.00
DURECT (DRRX) United States $0.170B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.170B 0.00
ContraFect (CFRX) United States $0.165B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.162B 0.00
Lannett Co Inc (LCI) United States $0.161B 1.33
BioLineRx (BLRX) Israel $0.154B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.153B 0.00
Infinity Pharmaceuticals (INFI) United States $0.152B 0.00
India Globalization Capital (IGC) United States $0.152B 0.00
Adherex Technologies (FENC) United States $0.151B 0.00
Recro Pharma (REPH) United States $0.150B 0.00
Nature's Sunshine Products (NATR) United States $0.149B 0.00
ProNAi Therapeutics (SRRA) Canada $0.144B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.141B 0.00
Champions Oncology (CSBR) United States $0.138B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.128B 0.00
Neos Therapeutics (NEOS) United States $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.121B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
ENTASIS THERAPT (ETTX) United States $0.102B 0.00
Forward Pharma (FWP) Denmark $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Iterum Therapeutics (ITRM) Ireland $0.085B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.082B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Immune Design (IMDZ) United States $0.078B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.076B 0.00
Nivalis Therapeutics (ALPN) United States $0.073B 0.00
Natural Alternatives (NAII) United States $0.072B 8.05
Novan (NOVN) United States $0.071B 0.00
Genocea Biosciences (GNCA) United States $0.066B 0.00
Trillium Therapeutics (TRIL) Canada $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 40.48
SCYNEXIS (SCYX) United States $0.050B 0.00
Mannatechorporated (MTEX) United States $0.048B 25.30
Ampio Pharmaceuticals (AMPE) United States $0.048B 0.00
Capnia (SLNO) United States $0.043B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
Heat Biologics (HTBX) United States $0.041B 0.00
KemPharm (KMPH) United States $0.040B 0.00
Avenue Therapeutics (ATXI) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
XTL Biopharmaceuticals (XTLB) Israel $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.034B 0.00
IsoRay (ISR) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.032B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.027B 9.75
Biomerica (BMRA) United States $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Aviragen Therapeutics (VXRT) United States $0.025B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Aradigm (ARDM) United States $0.019B 0.00
Shineco (TYHT) China $0.019B 1.88
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Midatech Pharma (MTP) United Kingdom $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Pain Therapeutics (PTIE) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
PharmAthene (ALT) United States $0.008B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00